OBJECTIVE: To compare the health-related quality of life (HR-QOL) in acute respiratory distress syndrome (ARDS) survivors with that in a matched control group of non-ARDS survivors. DESIGN AND SETTING: Prospective, matched, parallel cohort study, comparing HR-QOL between intensive care unit (ICU) survivors with ARDS and a control group in a tertiary care hospital. PATIENTS: Between May 1997 and December 2000, all ARDS adult patients of an eight-bed medical/surgical unit of a tertiary care hospital were enrolled and a control group of non-ARDS survivors, matched for severity of disease and for previous health state, was selected. The study included 29 ARDS survivors who answered the EQ-5D questionnaire and had lung function evaluated. MEASUREMENTS AND RESULTS: A follow-up appointment was performed 6 months after ICU discharge consisting of: (a) evaluation of HR-QOL using EQ-5D and (b) lung function tests and measure of diffusing capacity. Among ARDS survivors 41% had normal lung function and 59% mild to moderate lung function impairments. Nearly a one-third of ARDS survivors reported problems in one or more of the five dimensions of the EQ-5D, and 48% reported feeling worse at the interview than 6 month before ICU admission. No significant differences were found in HR-QOL between ARDS survivors and other ICU survivors with similar age and matched for previous health state and severity of disease. CONCLUSIONS: This study suggests that impairments in HR-QOL among ARDS survivors may not be distinguishable from that among other ICU survivors.
OBJECTIVE: To compare the health-related quality of life (HR-QOL) in acute respiratory distress syndrome (ARDS) survivors with that in a matched control group of non-ARDS survivors. DESIGN AND SETTING: Prospective, matched, parallel cohort study, comparing HR-QOL between intensive care unit (ICU) survivors with ARDS and a control group in a tertiary care hospital. PATIENTS: Between May 1997 and December 2000, all ARDS adult patients of an eight-bed medical/surgical unit of a tertiary care hospital were enrolled and a control group of non-ARDS survivors, matched for severity of disease and for previous health state, was selected. The study included 29 ARDS survivors who answered the EQ-5D questionnaire and had lung function evaluated. MEASUREMENTS AND RESULTS: A follow-up appointment was performed 6 months after ICU discharge consisting of: (a) evaluation of HR-QOL using EQ-5D and (b) lung function tests and measure of diffusing capacity. Among ARDS survivors 41% had normal lung function and 59% mild to moderate lung function impairments. Nearly a one-third of ARDS survivors reported problems in one or more of the five dimensions of the EQ-5D, and 48% reported feeling worse at the interview than 6 month before ICU admission. No significant differences were found in HR-QOL between ARDS survivors and other ICU survivors with similar age and matched for previous health state and severity of disease. CONCLUSIONS: This study suggests that impairments in HR-QOL among ARDS survivors may not be distinguishable from that among other ICU survivors.
Authors: M B Hamel; R S Phillips; R B Davis; J Teno; A F Connors; N Desbiens; J Lynn; N V Dawson; W Fulkerson; J Tsevat Journal: Am J Med Date: 2000-12-01 Impact factor: 4.965
Authors: G Schelling; C Stoll; M Haller; J Briegel; W Manert; T Hummel; A Lenhart; M Heyduck; J Polasek; M Meier; U Preuss; M Bullinger; W Schüffel; K Peter Journal: Crit Care Med Date: 1998-04 Impact factor: 7.598
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R LeGall; A Morris; R Spragg Journal: Intensive Care Med Date: 1994 Impact factor: 17.440
Authors: D C Angus; A A Musthafa; G Clermont; M F Griffin; W T Linde-Zwirble; T T Dremsizov; M R Pinsky Journal: Am J Respir Crit Care Med Date: 2001-05 Impact factor: 21.405
Authors: Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2004-06-26 Impact factor: 17.440
Authors: Guangxi Li; Marija Kojicic; Martin K Reriani; Evans R Fernández Pérez; Lokendra Thakur; Rahul Kashyap; Camille M Van Buskirk; Ognjen Gajic Journal: Chest Date: 2009-10-16 Impact factor: 9.410
Authors: David W Dowdy; Mark P Eid; Cheryl R Dennison; Pedro A Mendez-Tellez; Margaret S Herridge; Eliseo Guallar; Peter J Pronovost; Dale M Needham Journal: Intensive Care Med Date: 2006-06-17 Impact factor: 17.440
Authors: David W Dowdy; Dale M Needham; Pedro A Mendez-Tellez; Margaret S Herridge; Peter J Pronovost Journal: Intensive Care Med Date: 2005-05-21 Impact factor: 17.440
Authors: Maina M B Morales; Ruy C Pires-Neto; Nicole Inforsato; Tatiana Lanças; Luiz F F da Silva; Paulo H N Saldiva; Thais Mauad; Carlos R R Carvalho; Marcelo B P Amato; Marisa Dolhnikoff Journal: Crit Care Date: 2011-01-06 Impact factor: 9.097